Cell Gene Therapy Manufacturing Services Market Size, Share 2022

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis By Cell Therapy
1.2.1 Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate By Cell Therapy: 2017 VS 2021 VS 2028
1.2.2 Allogeneic
1.2.3 Autologous
1.2.4 Viral Vector
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oncology Diseases
1.3.3 Cardiovascular Diseases
1.3.4 Orthopedic Diseases
1.3.5 Ophthalmology Diseases
1.3.6 Infectious Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing Services Market Perspective (2017-2028)
2.2 Cell and Gene Therapy Manufacturing Services Growth Trends by Region
2.2.1 Cell and Gene Therapy Manufacturing Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell and Gene Therapy Manufacturing Services Historic Market Size by Region (2017-2022)
2.2.3 Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Region (2023-2028)
2.3 Cell and Gene Therapy Manufacturing Services Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing Services Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing Services Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing Services Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing Services Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing Services Players by Revenue (2017-2022)
3.1.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Players (2017-2022)
3.2 Global Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing Services Revenue
3.4 Global Cell and Gene Therapy Manufacturing Services Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing Services Revenue in 2021
3.5 Cell and Gene Therapy Manufacturing Services Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing Services Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing Services Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing Services Historic Market Size by Type (2017-2022)
4.2 Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Type (2023-2028)
5 Cell and Gene Therapy Manufacturing Services Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing Services Historic Market Size by Application (2017-2022)
5.2 Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
6.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
6.3 North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
7.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
7.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
9.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
9.3 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Introduction
11.2.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.2.5 Merck KGaA Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Introduction
11.3.4 Charles River Laboratories Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.3.5 Charles River Laboratories Recent Development
11.4 Lonza
11.4.1 Lonza Company Detail
11.4.2 Lonza Business Overview
11.4.3 Lonza Cell and Gene Therapy Manufacturing Services Introduction
11.4.4 Lonza Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.4.5 Lonza Recent Development
11.5 Catalent
11.5.1 Catalent Company Detail
11.5.2 Catalent Business Overview
11.5.3 Catalent Cell and Gene Therapy Manufacturing Services Introduction
11.5.4 Catalent Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.5.5 Catalent Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Detail
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Introduction
11.6.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.6.5 WuXi AppTec Recent Development
11.7 Takara Bio Inc
11.7.1 Takara Bio Inc Company Detail
11.7.2 Takara Bio Inc Business Overview
11.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Introduction
11.7.4 Takara Bio Inc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.7.5 Takara Bio Inc Recent Development
11.8 Nikon Corporation
11.8.1 Nikon Corporation Company Detail
11.8.2 Nikon Corporation Business Overview
11.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Introduction
11.8.4 Nikon Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.8.5 Nikon Corporation Recent Development
11.9 FUJIFILM Holdings Corporation
11.9.1 FUJIFILM Holdings Corporation Company Detail
11.9.2 FUJIFILM Holdings Corporation Business Overview
11.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Introduction
11.9.4 FUJIFILM Holdings Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.9.5 FUJIFILM Holdings Corporation Recent Development
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Detail
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.10.5 F. Hoffmann-La Roche Recent Development
11.11 Oxford Biomedica Plc
11.11.1 Oxford Biomedica Plc Company Detail
11.11.2 Oxford Biomedica Plc Business Overview
11.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Introduction
11.11.4 Oxford Biomedica Plc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.11.5 Oxford Biomedica Plc Recent Development
11.12 Cell and Gene Therapy Catapult
11.12.1 Cell and Gene Therapy Catapult Company Detail
11.12.2 Cell and Gene Therapy Catapult Business Overview
11.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Introduction
11.12.4 Cell and Gene Therapy Catapult Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.12.5 Cell and Gene Therapy Catapult Recent Development
11.13 The Discovery Labs LLC
11.13.1 The Discovery Labs LLC Company Detail
11.13.2 The Discovery Labs LLC Business Overview
11.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Introduction
11.13.4 The Discovery Labs LLC Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.13.5 The Discovery Labs LLC Recent Development
11.14 RoslinCT
11.14.1 RoslinCT Company Detail
11.14.2 RoslinCT Business Overview
11.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Introduction
11.14.4 RoslinCT Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.14.5 RoslinCT Recent Development
11.15 JRS PHARMA
11.15.1 JRS PHARMA Company Detail
11.15.2 JRS PHARMA Business Overview
11.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Introduction
11.15.4 JRS PHARMA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.15.5 JRS PHARMA Recent Development
11.16 FinVector
11.16.1 FinVector Company Detail
11.16.2 FinVector Business Overview
11.16.3 FinVector Cell and Gene Therapy Manufacturing Services Introduction
11.16.4 FinVector Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.16.5 FinVector Recent Development
11.17 ABL
11.17.1 ABL Company Detail
11.17.2 ABL Business Overview
11.17.3 ABL Cell and Gene Therapy Manufacturing Services Introduction
11.17.4 ABL Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.17.5 ABL Recent Development
11.18 Resilience
11.18.1 Resilience Company Detail
11.18.2 Resilience Business Overview
11.18.3 Resilience Cell and Gene Therapy Manufacturing Services Introduction
11.18.4 Resilience Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.18.5 Resilience Recent Development
11.19 BioCentriq
11.19.1 BioCentriq Company Detail
11.19.2 BioCentriq Business Overview
11.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Introduction
11.19.4 BioCentriq Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.19.5 BioCentriq Recent Development
11.20 Porton Biopharma Limited
11.20.1 Porton Biopharma Limited Company Detail
11.20.2 Porton Biopharma Limited Business Overview
11.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Introduction
11.20.4 Porton Biopharma Limited Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.20.5 Porton Biopharma Limited Recent Development
11.21 Andelyn Biosciences
11.21.1 Andelyn Biosciences Company Detail
11.21.2 Andelyn Biosciences Business Overview
11.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Introduction
11.21.4 Andelyn Biosciences Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.21.5 Andelyn Biosciences Recent Development
11.22 Commercializing Living Therapies
11.22.1 Commercializing Living Therapies Company Detail
11.22.2 Commercializing Living Therapies Business Overview
11.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Introduction
11.22.4 Commercializing Living Therapies Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.22.5 Commercializing Living Therapies Recent Development
11.23 Vibalogics
11.23.1 Vibalogics Company Detail
11.23.2 Vibalogics Business Overview
11.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Introduction
11.23.4 Vibalogics Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.23.5 Vibalogics Recent Development
11.24 Anemocyte Srl
11.24.1 Anemocyte Srl Company Detail
11.24.2 Anemocyte Srl Business Overview
11.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Introduction
11.24.4 Anemocyte Srl Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.24.5 Anemocyte Srl Recent Development
11.25 ElevateBio
11.25.1 ElevateBio Company Detail
11.25.2 ElevateBio Business Overview
11.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Introduction
11.25.4 ElevateBio Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.25.5 ElevateBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Key Players of Viral Vector
Table 5. Global Cell and Gene Therapy Manufacturing Services Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cell and Gene Therapy Manufacturing Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Cell and Gene Therapy Manufacturing Services Market Share by Region (2017-2022)
Table 9. Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Cell and Gene Therapy Manufacturing Services Market Share by Region (2023-2028)
Table 11. Cell and Gene Therapy Manufacturing Services Market Trends
Table 12. Cell and Gene Therapy Manufacturing Services Market Drivers
Table 13. Cell and Gene Therapy Manufacturing Services Market Challenges
Table 14. Cell and Gene Therapy Manufacturing Services Market Restraints
Table 15. Global Cell and Gene Therapy Manufacturing Services Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Cell and Gene Therapy Manufacturing Services Market Share by Players (2017-2022)
Table 17. Global Top Cell and Gene Therapy Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Services as of 2021)
Table 18. Ranking of Global Top Cell and Gene Therapy Manufacturing Services Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Manufacturing Services Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell and Gene Therapy Manufacturing Services Product Solution and Service
Table 22. Date of Enter into Cell and Gene Therapy Manufacturing Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Type (2017-2022)
Table 26. Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Type (2023-2028)
Table 28. Global Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Application (2017-2022)
Table 30. Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Application (2023-2028)
Table 32. North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028) & (US$ Million)
Table 42. Thermo Fisher Scientific Company Detail
Table 43. Thermo Fisher Scientific Business Overview
Table 44. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product
Table 45. Thermo Fisher Scientific Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 46. Thermo Fisher Scientific Recent Development
Table 47. Merck KGaA Company Detail
Table 48. Merck KGaA Business Overview
Table 49. Merck KGaA Cell and Gene Therapy Manufacturing Services Product
Table 50. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 51. Merck KGaA Recent Development
Table 52. Charles River Laboratories Company Detail
Table 53. Charles River Laboratories Business Overview
Table 54. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product
Table 55. Charles River Laboratories Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 56. Charles River Laboratories Recent Development
Table 57. Lonza Company Detail
Table 58. Lonza Business Overview
Table 59. Lonza Cell and Gene Therapy Manufacturing Services Product
Table 60. Lonza Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 61. Lonza Recent Development
Table 62. Catalent Company Detail
Table 63. Catalent Business Overview
Table 64. Catalent Cell and Gene Therapy Manufacturing Services Product
Table 65. Catalent Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 66. Catalent Recent Development
Table 67. WuXi AppTec Company Detail
Table 68. WuXi AppTec Business Overview
Table 69. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product
Table 70. WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 71. WuXi AppTec Recent Development
Table 72. Takara Bio Inc Company Detail
Table 73. Takara Bio Inc Business Overview
Table 74. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product
Table 75. Takara Bio Inc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 76. Takara Bio Inc Recent Development
Table 77. Nikon Corporation Company Detail
Table 78. Nikon Corporation Business Overview
Table 79. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product
Table 80. Nikon Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 81. Nikon Corporation Recent Development
Table 82. FUJIFILM Holdings Corporation Company Detail
Table 83. FUJIFILM Holdings Corporation Business Overview
Table 84. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product
Table 85. FUJIFILM Holdings Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 86. FUJIFILM Holdings Corporation Recent Development
Table 87. F. Hoffmann-La Roche Company Detail
Table 88. F. Hoffmann-La Roche Business Overview
Table 89. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product
Table 90. F. Hoffmann-La Roche Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 91. F. Hoffmann-La Roche Recent Development
Table 92. Oxford Biomedica Plc Company Detail
Table 93. Oxford Biomedica Plc Business Overview
Table 94. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing ServicesProduct
Table 95. Oxford Biomedica Plc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 96. Oxford Biomedica Plc Recent Development
Table 97. Cell and Gene Therapy Catapult Company Detail
Table 98. Cell and Gene Therapy Catapult Business Overview
Table 99. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing ServicesProduct
Table 100. Cell and Gene Therapy Catapult Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 101. Cell and Gene Therapy Catapult Recent Development
Table 102. The Discovery Labs LLC Company Detail
Table 103. The Discovery Labs LLC Business Overview
Table 104. The Discovery Labs LLC Cell and Gene Therapy Manufacturing ServicesProduct
Table 105. The Discovery Labs LLC Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 106. The Discovery Labs LLC Recent Development
Table 107. RoslinCT Company Detail
Table 108. RoslinCT Business Overview
Table 109. RoslinCT Cell and Gene Therapy Manufacturing ServicesProduct
Table 110. RoslinCT Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 111. RoslinCT Recent Development
Table 112. JRS PHARMA Company Detail
Table 113. JRS PHARMA Business Overview
Table 114. JRS PHARMA Cell and Gene Therapy Manufacturing ServicesProduct
Table 115. JRS PHARMA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 116. JRS PHARMA Recent Development
Table 117. FinVector Company Detail
Table 118. FinVector Business Overview
Table 119. FinVector Cell and Gene Therapy Manufacturing ServicesProduct
Table 120. FinVector Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 121. FinVector Recent Development
Table 122. ABL Company Detail
Table 123. ABL Business Overview
Table 124. ABL Cell and Gene Therapy Manufacturing ServicesProduct
Table 125. ABL Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 126. ABL Recent Development
Table 127. Resilience Company Detail
Table 128. Resilience Business Overview
Table 129. Resilience Cell and Gene Therapy Manufacturing ServicesProduct
Table 130. Resilience Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 131. Resilience Recent Development
Table 132. BioCentriq Company Detail
Table 133. BioCentriq Business Overview
Table 134. BioCentriq Cell and Gene Therapy Manufacturing ServicesProduct
Table 135. BioCentriq Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 136. BioCentriq Recent Development
Table 137. Porton Biopharma Limited Company Detail
Table 138. Porton Biopharma Limited Business Overview
Table 139. Porton Biopharma Limited Cell and Gene Therapy Manufacturing ServicesProduct
Table 140. Porton Biopharma Limited Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 141. Porton Biopharma Limited Recent Development
Table 142. Andelyn Biosciences Company Detail
Table 143. Andelyn Biosciences Business Overview
Table 144. Andelyn Biosciences Cell and Gene Therapy Manufacturing ServicesProduct
Table 145. Andelyn Biosciences Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 146. Andelyn Biosciences Recent Development
Table 147. Commercializing Living Therapies Company Detail
Table 148. Commercializing Living Therapies Business Overview
Table 149. Commercializing Living Therapies Cell and Gene Therapy Manufacturing ServicesProduct
Table 150. Commercializing Living Therapies Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 151. Commercializing Living Therapies Recent Development
Table 152. Vibalogics Company Detail
Table 153. Vibalogics Business Overview
Table 154. Vibalogics Cell and Gene Therapy Manufacturing ServicesProduct
Table 155. Vibalogics Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 156. Vibalogics Recent Development
Table 157. Anemocyte Srl Company Detail
Table 158. Anemocyte Srl Business Overview
Table 159. Anemocyte Srl Cell and Gene Therapy Manufacturing ServicesProduct
Table 160. Anemocyte Srl Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 161. Anemocyte Srl Recent Development
Table 162. ElevateBio Company Detail
Table 163. ElevateBio Business Overview
Table 164. ElevateBio Cell and Gene Therapy Manufacturing ServicesProduct
Table 165. ElevateBio Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million)
Table 166. ElevateBio Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Manufacturing Services Market Share by Type: 2021 VS 2028
Figure 2. Allogeneic Features
Figure 3. Autologous Features
Figure 4. Viral Vector Features
Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Share by Application in 2021 & 2028
Figure 6. Oncology Diseases Case Studies
Figure 7. Cardiovascular Diseases Case Studies
Figure 8. Orthopedic Diseases Case Studies
Figure 9. Ophthalmology Diseases Case Studies
Figure 10. Infectious Diseases Case Studies
Figure 11. Others Case Studies
Figure 12. Cell and Gene Therapy Manufacturing Services Report Years Considered
Figure 13. Global Cell and Gene Therapy Manufacturing Services Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Cell and Gene Therapy Manufacturing Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Cell and Gene Therapy Manufacturing Services Market Share by Region: 2021 VS 2028
Figure 16. Global Cell and Gene Therapy Manufacturing Services Market Share by Players in 2021
Figure 17. Global Top Cell and Gene Therapy Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Services as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2021
Figure 19. North America Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Cell and Gene Therapy Manufacturing Services Market Share by Country (2017-2028)
Figure 21. United States Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Cell and Gene Therapy Manufacturing Services Market Share by Country (2017-2028)
Figure 25. Germany Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Share by Region (2017-2028)
Figure 33. China Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Cell and Gene Therapy Manufacturing Services Market Share by Country (2017-2028)
Figure 41. Mexico Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Share by Country (2017-2028)
Figure 45. Turkey Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Cell and Gene Therapy Manufacturing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 48. Merck KGaA Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 49. Charles River Laboratories Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 50. Lonza Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 51. Catalent Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 52. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 53. Takara Bio Inc Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 54. Nikon Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 55. FUJIFILM Holdings Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 56. F. Hoffmann-La Roche Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 57. Oxford Biomedica Plc Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 58. Cell and Gene Therapy Catapult Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 59. The Discovery Labs LLC Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 60. RoslinCT Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 61. JRS PHARMA Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 62. FinVector Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 63. ABL Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 64. Resilience Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 65. BioCentriq Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 66. Porton Biopharma Limited Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 67. Andelyn Biosciences Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 68. Commercializing Living Therapies Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 69. Vibalogics Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 70. Anemocyte Srl Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 71. ElevateBio Revenue Growth Rate in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

DOWNLOAD SAMPLE